[HTML][HTML] Six intragastric balloons: Which to choose?

G Stavrou, A Shrewsbury… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Endoscopically placed intragastric balloons (IGBs) have played a significant role in obesity
treatment over the last 30 years, successfully bridging the gap between lifestyle modification …

Pharmacogenomics of Medication‐Induced Weight Gain and Antiobesity Medications

S Singh, ML Ricardo‐Silgado, SJ Bielinski, A Acosta - Obesity, 2021 - Wiley Online Library
Obesity is a chronic, multifactorial disease associated with a large number of comorbidities.
The clinical management of obesity involves a stepwise integrated approach, beginning with …

[HTML][HTML] Endoscopic bariatrics: current therapies and future directions

D Reja, C Zhang, A Sarkar - Translational Gastroenterology and …, 2022 - ncbi.nlm.nih.gov
Endoscopic bariatric therapies (EBTs) are endoscopic procedures indicated for weight loss
in the obese population. They are shown to be safe and effective for patients who do not …

Management of obesity and nonalcoholic fatty liver disease: a literature review

A Hashem, A Khalouf, A Acosta - Seminars in liver disease, 2021 - thieme-connect.com
With the recent urbanization and globalization, the adult obesity rate has been increasing,
which was paralleled with a dramatic surge in the incidence and prevalence of nonalcoholic …

Development of bariatric and metabolic endoscopy

SH Li, YJ Wang, ST Zhang - Chinese Medical Journal, 2018 - mednexus.org
Objective: With the evolution of society and changes in human lifestyle, obesity is becoming
increasingly prevalent worldwide, and obesity-related comorbidities such as diabetes …

Hígado graso: una epidemia silente

JEP Ortiz - Medicina, 2022 - revistamedicina.net
El hígado graso o NAFLD afecta aproximadamente al 25% de la población mundial y es
una de las primeras causas de consulta en los servicios de hepatología y de especialistas …

The Gastrointestinal System and Obesity

G Calderón, A Acosta - Dietary Interventions in Gastrointestinal Diseases, 2019 - Elsevier
The gastrointestinal (GI) system plays a key role in obesity. Obesity is a complex disease in
which the excess of adiposity results in increased health risks and disease. The excess of …

[PDF][PDF] Scope of Policy

LA Silicone - Policy, 2023 - asmbs.org
Open or laparoscopic short or long-limb Roux-en-Y gastric bypass (RYGB), open or
laparoscopic sleeve gastrectomy, open or laparoscopic biliopancreatic diversion (BPD) with …

[PDF][PDF] LONG-TERM OUTCOMES OF LAPAROSCOPIC SLEEVE GASTRECTOMY VS. LAPAROSCOPIC ROUX-EN-Y GASTRIC BYPASS

S Grönroos - utupub.fi
Background: Severe obesity is an increasing global epidemic. To date, metabolic bariatric
surgery (MBS) is the only treatment for severe obesity with good and sustainable long-term …

[PDF][PDF] CHENG King Fai. Natural Products to Slow Down Obesity. Arch Metabolic Synd; 2024; 4 (1): 1-4

PC LEUNG, E Wat - Correspondence: Leung Ping Chung, Institute of … - scivisionpub.com
Obesity has become an international health problem. Obesity could be a unique health
issue for affluent populations, but its correlations with chronic diseases like diabetes and …